Antimicrobial Resistance (AMR) Symposium
RSVP to Kara Hurley at [email protected]
Infectious Diseases
The impact of preventive treatment for multidrug- and rifampin-resistant tuberculosis exceeds trial-based estimates
ARTICLE: The impact of preventive treatment for multidrug- and rifampin-resistant tuberculosis exceeds trial-based estimates AUTHORS: Parastu Kasaie, Jeff Pennington, Amita Gupta, David W Dowdy, Emily A Kendall JOURNAL:… Read More »The impact of preventive treatment for multidrug- and rifampin-resistant tuberculosis exceeds trial-based estimates
Baltimore Magazine’s 2023 Top Doctors
Over 100 physicians from across Johns Hopkins Medicine were named on Baltimore magazine's 2023 Top Doctors List. Baltimore magazine surveys thousands of physicians in the Baltimore… Read More »Baltimore Magazine’s 2023 Top Doctors
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy
ARTICLE: The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy AUTHORS: Natalie F McMyn, Joseph Varriale, Emily J Fray,… Read More »The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy
Irvin Named JHHS Health Equity Program Director
Dr. Risha Irvin, associate professor in the Division of Infectious Diseases and vice chair for diversity, inclusion and health equity for the DOM, was appointed… Read More »Irvin Named JHHS Health Equity Program Director
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis
ARTICLE: 1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis AUTHORS: Sonya Krishnan, Xingye Wu, Soyeon Kim, Katie McIntire, Linda Naini, Michael D Hughes, Rodney… Read More »1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis
Timely Second-Dose Completion of mRNA COVID-19 Vaccination at Community-Based and Mobile Vaccine Clinics in Maryland
ARTICLE: Timely Second-Dose Completion of mRNA COVID-19 Vaccination at Community-Based and Mobile Vaccine Clinics in Maryland AUTHORS: Cassandra Parent, Benjamin F Bigelow, Stephen D Sisson, Diego Martínez, Cui Yang, Kathleen… Read More »Timely Second-Dose Completion of mRNA COVID-19 Vaccination at Community-Based and Mobile Vaccine Clinics in Maryland
Incident COVID-19 and Hospitalizations by Variant Era Among Vaccinated Solid Organ Transplant Recipients
ARTICLE: Incident COVID-19 and Hospitalizations by Variant Era Among Vaccinated Solid Organ Transplant Recipients AUTHORS: Teresa Po-Yu Chiang, Aura T Abedon, Jennifer L Alejo, Dorry L Segev, Allan B… Read More »Incident COVID-19 and Hospitalizations by Variant Era Among Vaccinated Solid Organ Transplant Recipients
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations
ARTICLE: Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations AUTHORS: Jordan J Feld, Julie Bruneau, Gregory J Dore, Marc G Ghany, Bettina Hansen, Mark Sulkowski, David… Read More »Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations
Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial
ARTICLE: Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the… Read More »Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial